Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.
- DOI
- 10.1007/s41030-026-00361-2
- Published
- 2026 Sep
- Container
- Pulmonary therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s41030-026-00361-2,
title = {Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.},
author = {Bhatt SP and Rabe KF and Hanania NA and Vogelmeier CF and Bafadhel M and Christenson SA and Papi A and Singh D and Walsh L and Winders T and Bansal A and Robinson LB},
year = {2026},
journal = {Pulmonary therapy},
doi = {10.1007/s41030-026-00361-2},
url = {https://doi.org/10.1007/s41030-026-00361-2}
}RIS
TY - JOUR TI - Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials. AU - Bhatt SP AU - Rabe KF AU - Hanania NA AU - Vogelmeier CF AU - Bafadhel M AU - Christenson SA AU - Papi A AU - Singh D AU - Walsh L AU - Winders T AU - Bansal A AU - Robinson LB PY - 2026 JO - Pulmonary therapy DO - 10.1007/s41030-026-00361-2 UR - https://doi.org/10.1007/s41030-026-00361-2 ER -
APA
SP, B., KF, R., NA, H., CF, V., M, B., SA, C., A, P., D, S., L, W., T, W., A, B., & LB, R. (2026). Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.. Pulmonary therapy. https://doi.org/10.1007/s41030-026-00361-2
Source records
- pubmed · retrieved 2026-09-25T09:29:45.926Z
- europe-pmc · retrieved 2026-09-25T09:29:45.924Z
- doaj · retrieved 2026-09-25T09:29:45.903Z